SPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并

智通财经01-19

智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2404957736?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-01-19 20:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2404957736","market":"us","top_or_hot":-1,"title":"SPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1058422.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-19 20:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1058422.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1058422.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RCFA.U","symbol_name":"RCF Acquisition Corp.","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1058422.html","article_id":"2404957736","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2404957736","pubTimestamp":1705666771,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，特殊目的收购公司Bowen Acquisition宣布，已与深圳仟枝生物科技有限公司达成最终合并协议。根据协议，深圳仟枝生物科技有限公司将成为Bowen Acquisition的全资子公司。前者的股东将获得总计725万股Bowen Acquisition普通股，并可能在达到一定的盈利目标后获得额外的140万股Bowen Acquisition普通股。深圳仟枝生物科技有限公司在一份声明中表示，合并后的公司将继续由其执行管理团队领导。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"RCFA.U":"RCF Acquisition Corp.","VAQC":"Vector Acquisition Corporation II","TLGYU":"TLGY Acquisition Corp","PEGR":"Project Energy Reimagined Acquisition Corp","PHYT.U":"Pyrophyte Acquisition Corp.","SSPKU":"Silver Spike Acquisition Corp.","ACRO":"Acropolis Infrastructure Acquisition Corp.","MNTN.U":"Everest Consolidator Acquisition Corp","TSIAU":"TS Innovation Acquisitions Corp.","OHAA":"OPY Acquisition Corp I","OHAAU":"OPY Acquisition Corp I","SUAC.U":"ShoulderUP Technology Acquisition Corp.","KVAC":"KEEN VISION ACQUISITION CORPORATION","AAQC":"Accelerate Acquisition Corp","LOCC.U":"Live Oak Crestview Climate Acquisition Corp.","ATMV":"ALPHAVEST ACQUISITION CORP","AAQC.U":"Accelerate Acquisition Corp.","NVAC":"Northview Acquisition Corp","ATMVU":"ALPHAVEST ACQUISITION CORP UNITS 1 ORD SHS & 1 RT 1/10 SHS","OXUSU":"Oxus Acquisition Corp.","PLTNU":"PLUTONIAN ACQUISITION CORP UNIT 1 C UNIT 1 COM 1 WT EXP & 1 RT","SHAP.U":"Spree Acquisition Corp. I Ltd.","NVACU":"NorthView Acquisition Corp","PHYT":"Pyrophyte Acquisition Corp","SVII":"Spring Valley Acquisition Corp II","LGV":"Longview Acquisition Corp II","OSI.U":"Osiris Acquisition Corp.","SVIIU":"Spring Valley Acquisition Corp. II","MSSAU":"Metal Sky Star Acquisition Corp","NPAB":"New Providence Acquisition Corp II","TENKU":"TenX Keane Acquisition","BOWN":"Bowen Acquisition Corp","NPABU":"New Providence Acquisition Corp II","TENK":"TENX KEANE ACQUISITION","CNDA":"Concord Acquisition II Corp","TRCA.U":"Twin Ridge Capital Acquisition Corp.","QDROU":"Quadro Acquisition One Corp Unit 1 CL A & 1/3 RED WT EXP","DIST":"DISTOKEN ACQUISITION CORP","BOWNU":"Bowen Acquisition Corp.","MBAC":"M3-Brigade Acquisition II Corp","OTEC":"Oceantech Acquisitions I Corp.","PFTA":"Portage Fintech Acquisition Corporation","MCAAU":"Mountain & I Acquisition Co Corp","OCAXU":"OCA Acquisition Corp.","OTECU":"Oceantech Acquisitions I Corp.","ZLSWU":"Zalatoris II Acquisition Corp.","LIVBU":"LIV Capital Acquisition Corp II","WARR":"Warrior Technologies Acquisition Company","LIVB":"LIV Capital Acquisition Corp II","QOMOU":"Qomolangma Acquisition Corp","WARR.U":"Warrior Technologies Acquisition Company","MCADR":"Mountain Crest Acquisition Corp. II Rights","PUCK":"Goal Acquisitions Corp","TGVC":"TG Venture Acquisition Corp.","PUCKU":"Goal Acquisitions Corp.","TMTCU":"TMT Acquisition Corp.","WEL.U":"Integrated Wellness Acquisition Corp.","FORLU":"Four Leaf Acquisition Corp.","LWACU":"Locust Walk Acquisition Corp.","TMTC":"TMT ACQUISITION CORP","NNAGU":"99 Acquisition Group","MTRYU":"Monterey Bio Acquisition Corp","MTRY":"Monterey Bio Acquisition Corp","OSTRU":"Oyster Enterprises Acquisition Corp.","NFNT":"Infinite Acquisition Corp.","OPA.U":"Magnum Opus Acquisition Limited","IVCA":"Investcorp India Acquisition Corp","NFNT.U":"Infinite Acquisition Corp.","CETU":"Cetus Capital Acquisition Corp","SHUAU":"SHUAA Partners Acquisition Corp I","TRTL.U":"TortoiseEcofin Acquisition Corp. III","SEDA.U":"SDCL EDGE Acquisition Corp.","ONYXU":"Onyx Acquisition Co I","NFYS":"ENPHYS ACQUISITION CORP.","NFYS.U":"ENPHYS ACQUISITION CORP.","TCOA":"Trajectory Alpha Acquisition Corp.","NRACU":"NORTHERN REVIVAL ACQUISITION CORPORATION (1 CL A & 1/2 RED WT)","OAKU":"Oak Woods Acquisition Corp","RACY":"Relativity Acquisition Corp","RRAC.U":"Rigel Resource Acquisition Corp.","RACYU":"Relativity Acquisition Corp","OAKUU":"Oak Woods Acquisition Corp.","RMGBU":"ReNew Energy Global plc","RWODU":"Redwoods Acquisition Corp","PACI.U":"PROOF Acquisition Corp I","XFIN":"ExcelFin Acquisition Corp","IPXX":"Inflection Point Acquisition Corp II","WNNR.U":"Andretti Acquisition Corp.","MOTNU":"Motion Acquisition Corp.","SLAC":"Social Leverage Acquisition Corp I","SCRMU":"Screaming Eagle Acquisition Corp","SAMAU":"Schultze Special Purpose Acquisition Corp. II","VCXB.U":"10X Capital Venture Acquisition Corp. III","ROSS.U":"Ross Acquisition Corp II","VCXB":"10X Capital Venture Acquisition Corp. III","HSPO":"Horizon Space Acquisition I Corp"},"translate_title":"SPAC Bowen Acquisition (BOWN.US) merged with Shenzhen Qianzhi Biotechnology","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AAQC":1,"AAQC.U":1,"ACRO":1,"ATMV":1,"ATMVU":1,"BOWN":1,"BOWNU":1,"CETU":1,"CNDA":1,"DIST":1,"FORLU":1,"HSPO":1,"IPXX":1,"IVCA":1,"KVAC":1,"LGV":1,"LIVB":1,"LIVBU":1,"LOCC.U":1,"LWACU":1,"MBAC":1,"MCAAU":1,"MCADR":1,"MNTN.U":1,"MOTNU":1,"MSSAU":1,"MTRY":1,"MTRYU":1,"NFNT":1,"NFNT.U":1,"NFYS":1,"NFYS.U":1,"NNAGU":1,"NPAB":1,"NPABU":1,"NRACU":1,"NVAC":1,"NVACU":1,"OAKU":1,"OAKUU":1,"OCAXU":1,"OHAA":1,"OHAAU":1,"ONYXU":1,"OPA.U":1,"OSI.U":1,"OSTRU":1,"OTEC":1,"OTECU":1,"OXUS":1,"OXUSU":1,"PACI.U":1,"PEGR":1,"PEPLU":1,"PFTA":1,"PHYT":1,"PHYT.U":1,"PLTNU":1,"PORT.U":1,"PUCK":1,"PUCKU":1,"QDROU":1,"QOMOU":1,"RACY":1,"RACYU":1,"RCFA.U":1,"RMGBU":1,"ROSS.U":1,"RRAC.U":1,"RWODU":1,"SAMAU":1,"SCRMU":1,"SEDA.U":1,"SHAP.U":1,"SHUAU":1,"SLAC":1,"SSPKU":1,"SUAC.U":1,"SVII":1,"SVIIU":1,"SZZL":1,"TCOA":1,"TENK":1,"TENKU":1,"TGVC":1,"TLGYU":1,"TMTC":1,"TMTCU":1,"TRCA.U":1,"TRTL.U":1,"TSIAU":1,"VAQC":1,"VCXB":1,"VCXB.U":1,"WARR":1,"WARR.U":1,"WEL.U":1,"WNNR.U":1,"XFIN":1,"XPDB":1,"XPDBU":1,"ZLSWU":1},"content_text":"智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将成为Bowen Acquisition的全资子公司。前者的股东将获得总计725万股Bowen Acquisition普通股，并可能在达到一定的盈利目标后获得额外的140万股Bowen Acquisition普通股。深圳仟枝生物科技有限公司在一份声明中表示，合并后的公司将继续由其执行管理团队领导。该公司还补充称，无法保证合并后的公司将继续在纳斯达克上市。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2404957736"}